Fayez Sarofim & Co. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,165 shares of the medical equipment provider’s stock after purchasing an additional 448 shares during the quarter. Fayez Sarofim & Co.’s holdings in Intuitive Surgical were worth $53,512,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. ETF Managers Group LLC bought a new position in Intuitive Surgical during the 2nd quarter worth approximately $110,000. Harvest Fund Management Co. Ltd bought a new position in Intuitive Surgical in the second quarter valued at approximately $120,000. Parallel Advisors LLC lifted its stake in Intuitive Surgical by 3.9% in the second quarter. Parallel Advisors LLC now owns 159 shares of the medical equipment provider’s stock valued at $149,000 after buying an additional 6 shares in the last quarter. Lincoln National Corp bought a new position in Intuitive Surgical in the third quarter valued at approximately $200,000. Finally, Advisors Capital Management LLC bought a new position in Intuitive Surgical in the third quarter valued at approximately $209,000. Hedge funds and other institutional investors own 32.81% of the company’s stock.
In other news, VP Jamie Samath sold 959 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $398.46, for a total value of $382,123.14. Following the completion of the transaction, the vice president now owns 536 shares of the company’s stock, valued at $213,574.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark J. Meltzer sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $1,025.00, for a total value of $512,500.00. Following the completion of the transaction, the senior vice president now directly owns 2,796 shares of the company’s stock, valued at approximately $2,865,900. The disclosure for this sale can be found here. Insiders sold 56,444 shares of company stock valued at $21,945,471 in the last three months. Company insiders own 2.20% of the company’s stock.
Intuitive Surgical, Inc. (NASDAQ ISRG) traded down $26.71 on Monday, reaching $369.95. 2,158,803 shares of the company traded hands, compared to its average volume of 970,224. Intuitive Surgical, Inc. has a 1-year low of $203.57 and a 1-year high of $405.05. The company has a market capitalization of $44,444.88, a PE ratio of 52.49, a price-to-earnings-growth ratio of 5.51 and a beta of 0.48.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.99 by $0.78. The business had revenue of $806.10 million during the quarter, compared to analysts’ expectations of $753.25 million. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. Intuitive Surgical’s revenue was up 18.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.06 earnings per share. analysts expect that Intuitive Surgical, Inc. will post 7.85 EPS for the current fiscal year.
ISRG has been the topic of a number of research reports. Wedbush reaffirmed a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 10th. Morgan Stanley reissued an “overweight” rating on shares of Intuitive Surgical in a research report on Tuesday, September 5th. Barclays reissued an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, October 20th. Goldman Sachs Group restated a “buy” rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Finally, Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $418.00 target price on the stock in a report on Wednesday, October 25th. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $155.78.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/04/fayez-sarofim-co-purchases-448-shares-of-intuitive-surgical-inc-isrg.html.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.